chr1-161236108-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005122.5(NR1I3):c.108-131C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.152 in 1,045,210 control chromosomes in the GnomAD database, including 12,997 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.12 ( 1348 hom., cov: 31)
Exomes 𝑓: 0.16 ( 11649 hom. )
Consequence
NR1I3
NM_005122.5 intron
NM_005122.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.418
Publications
7 publications found
Genes affected
NR1I3 (HGNC:7969): (nuclear receptor subfamily 1 group I member 3) This gene encodes a member of the nuclear receptor superfamily, and is a key regulator of xenobiotic and endobiotic metabolism. The protein binds to DNA as a monomer or a heterodimer with the retinoid X receptor and regulates the transcription of target genes involved in drug metabolism and bilirubin clearance, such as cytochrome P450 family members. Unlike most nuclear receptors, this transcriptional regulator is constitutively active in the absence of ligand but is regulated by both agonists and inverse agonists. Ligand binding results in translocation of this protein to the nucleus, where it activates or represses target gene transcription. These ligands include bilirubin, a variety of foreign compounds, steroid hormones, and prescription drugs. In addition to drug metabolism, the CAR protein is also reported to regulate genes involved in glucose metabolism, lipid metabolism, cell proliferation, and circadian clock regulation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2020]
NR1I3 Gene-Disease associations (from GenCC):
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.213 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.122 AC: 18589AN: 152108Hom.: 1344 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
18589
AN:
152108
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.157 AC: 140248AN: 892984Hom.: 11649 Cov.: 12 AF XY: 0.156 AC XY: 70072AN XY: 448332 show subpopulations
GnomAD4 exome
AF:
AC:
140248
AN:
892984
Hom.:
Cov.:
12
AF XY:
AC XY:
70072
AN XY:
448332
show subpopulations
African (AFR)
AF:
AC:
789
AN:
20674
American (AMR)
AF:
AC:
2588
AN:
19744
Ashkenazi Jewish (ASJ)
AF:
AC:
1623
AN:
16390
East Asian (EAS)
AF:
AC:
8769
AN:
33724
South Asian (SAS)
AF:
AC:
8802
AN:
55414
European-Finnish (FIN)
AF:
AC:
6121
AN:
42086
Middle Eastern (MID)
AF:
AC:
457
AN:
3856
European-Non Finnish (NFE)
AF:
AC:
105108
AN:
660430
Other (OTH)
AF:
AC:
5991
AN:
40666
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
5756
11512
17267
23023
28779
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3302
6604
9906
13208
16510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.122 AC: 18605AN: 152226Hom.: 1348 Cov.: 31 AF XY: 0.124 AC XY: 9211AN XY: 74426 show subpopulations
GnomAD4 genome
AF:
AC:
18605
AN:
152226
Hom.:
Cov.:
31
AF XY:
AC XY:
9211
AN XY:
74426
show subpopulations
African (AFR)
AF:
AC:
1684
AN:
41556
American (AMR)
AF:
AC:
1964
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
351
AN:
3470
East Asian (EAS)
AF:
AC:
1159
AN:
5188
South Asian (SAS)
AF:
AC:
796
AN:
4822
European-Finnish (FIN)
AF:
AC:
1547
AN:
10596
Middle Eastern (MID)
AF:
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10642
AN:
67994
Other (OTH)
AF:
AC:
277
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
846
1692
2537
3383
4229
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
218
436
654
872
1090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.